ArticleInflammopharmacology2025

Correction: The impact of tocilizumab treatment on the severity of inflammation and survival rates in sepsis is significantly influence by the timing of administration.

Taha Tavaci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.